You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01344369 ↗ Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions Completed Teva Pharmaceuticals USA Phase 1 2008-08-01 The purpose of this study was to evaluate the relative bioavailability of a test formulation of norethindrone/ethinyl estradiol 0.4 mg/0.035 mg chewable tablets (Teva Pharmaceuticals, USA) compared to the reference listed product, FEMCON® Fe (norethindrone/ethinyl estradiol and ferrous fumarate) 0.4 mg/0.035 mg Chewable tablets (Warner Chilcott) under fed conditions in healthy, non-tobacco using, adult female subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

Condition Name

Condition Name for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Intervention Trials
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

Trials by Country

Trials by Country for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

Clinical Trial Phase

Clinical Trial Phase for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE

Sponsor Name

Sponsor Name for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Sponsor Trials
Teva Pharmaceuticals USA 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
Sponsor Trials
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.